MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

16 May 2025 Evaluate
The revenue for the March 2025 quarter is pegged at Rs. 2173.00 millions, about 5.59% up against Rs. 2058.00 millions recorded during the year-ago period.Net Profit of the company move down -58.15% to Rs. 136.00  millions from Rs. 325.00 millions  in the same quarter last year.A decline of 439.00 millions was observed in the OP in the quarter ended March 2025 from 623.00 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 2173.00 2058.00 5.59 7457.00 7847.00 -4.97 7457.00 7847.00 -4.97
Other Income 179.00 501.00 -64.27 996.00 1034.00 -3.68 996.00 1034.00 -3.68
PBIDT 439.00 623.00 -29.53 1317.00 1199.00 9.84 1317.00 1199.00 9.84
Interest 70.00 81.00 -13.58 298.00 299.00 -0.33 298.00 299.00 -0.33
PBDT 369.00 542.00 -31.92 907.00 900.00 0.78 907.00 900.00 0.78
Depreciation 134.00 127.00 5.51 531.00 483.00 9.94 531.00 483.00 9.94
PBT 235.00 415.00 -43.37 376.00 417.00 -9.83 376.00 417.00 -9.83
TAX 99.00 90.00 10.00 184.00 101.00 82.18 184.00 101.00 82.18
Deferred Tax 17.00 22.00 -22.73 -14.00 33.00 -142.42 -14.00 33.00 -142.42
PAT 136.00 325.00 -58.15 192.00 316.00 -39.24 192.00 316.00 -39.24
Equity 159.00 159.00 0.00 159.00 159.00 0.00 159.00 159.00 0.00
PBIDTM(%) 20.20 30.27 -33.26 17.66 15.28 15.59 17.66 15.28 15.59
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..